Martin Madaus

Martin Madaus

Voorzitter bij REPLIGEN CORPORATION

Vermogen: 2 M $ op 31-05-2026

66 jaar
Health Technology
Commercial Services
Health Services

Profiel

Dr. Martin D.
Madaus
is an Independent Director at Azenta, Inc., a Chairman at Repligen Corp.
and an Executive Chairman at Emulate, Inc. He is on the Board of Directors at Azenta, Inc., Unchained Labs LLC, Candela Medical, Inc., Candela Corp., Massachusetts High Technology Council, Inc., Syntis Bio, Inc. and Ultivue, Inc. Dr. Madaus was previously employed as an Independent Director by Hologic, Inc., an Independent Director by Standard BioTools, Inc., a Chief Operations Officer by Sherlock Biosciences, Inc., a Chairman & Chief Executive Officer by Ortho-Clinical Diagnostics, Inc., an Independent Director by Covidien Ltd., an Independent Director by Mettler-Toledo International, Inc., a Chairman, President & Chief Executive Officer by Millipore Corp., a Chairman, President & Chief Executive Officer by Millipore SA/NV, a President & Chief Executive Officer by Roche Diagnostics Corp., a Chairman & Chief Executive Officer by Ortho-Clinical Diagnostics, and a Vice President-Business Development by Roche Molecular Systems, Inc. He also served on the board at Quanterix Corp., Analytical Life Science & Diagnostics Association, Massachusetts Technology Collaborative, New England Healthcare Institute, Pharmaceutical Product Development LLC, Predictive Biosciences, Inc. and Young Men's Christian Association of Greater Boston, Inc. He received his doctorate degree from Ludwig-Maximilians-Universität München and a doctorate degree from The University of Veterinary Medicine Hanover.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
14-05-2026 8.392 ( 0,01% ) 1 M $ 31-05-2026
02-01-2025 291.541 ( 0,63% ) 892 115 $ 31-05-2026
05-02-2026 7.405 ( 0,02% ) 169 426 $ 31-05-2026

Actieve functies van Martin Madaus

BedrijvenFunctieBegin
CANDELA MEDICAL, INC. Directeur/Bestuurslid 01-05-2018
REPLIGEN CORPORATION Voorzitter 13-03-2026
AZENTA, INC. Directeur/Bestuurslid 30-01-2024
Directeur/Bestuurslid -
Directeur/Bestuurslid -
Directeur/Bestuurslid 01-07-2021
Directeur/Bestuurslid -
Directeur/Bestuurslid -
Voorzitter 19-03-2020

Eerdere bekende functies van Martin Madaus

BedrijvenFunctieEinde
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
Ervaring van Martin Madaus in detail bekijken

Opleiding van Martin Madaus

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

68

Eerstegraads connecties

29

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit29

Health Technology

Health Technology

Commercial Services

Health Technology

Health Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Technology Services

Health Technology

Commercial Services

Health Services

Commercial Services

Health Services

Commercial Services

Electronic Technology

Analytical Life Science & Diagnostics Association

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Martin Madaus
-40 %: de beste tools exclusief voor abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU